Stemirna Therapeutics racks up about $200m: Reuters

Stemirna Therapeutics, a RNA technology- based drug developer, has raised about $200 million, reported Reuters.

Stemirna Therapeutics, a RNA technology- based drug developer, has raised about $200 million, reported Reuters. The investors included China Merchants Group’s health sector investment arm, Sequoia Capital China and WuXi AppTec.

Source: Reuters